{
  "id": 18447800,
  "title": "CG Bio Sponsors World UBE Congress in Melbourne",
  "url": "https://urgent.news/2026/11/06/cg-bio-sponsors-world-ube-congress-in-melbourne",
  "topic": "world",
  "section": "World",
  "published": "2026-11-06T05:46:51.000Z",
  "source": {
    "name": "BusinessKorea",
    "slug": "businesskorea",
    "url": "https://www.businesskorea.co.kr/news/articleView.html?idxno=280690"
  },
  "original_language": "en",
  "account": "Regenerative medicine company CG Bio sponsored the 2026 World UBE Society Australia Annual Congress held in Melbourne. The event focused on sharing advancements in unilateral biportal endoscopic surgery, also known as UBE. CG Bio showcased a wide range of products, from surgical instruments and imaging equipment to implants and bone regeneration biologics. During the congress, the company set up an exhibition booth at the RACV City Club and introduced key endoscopic spine surgery equipment. Multifocus, a surgical instrument set developed by CG MedTech, and ELICA 4K, a high-resolution 4K imaging system, were among the main products displayed.\n\nIn addition to surgical equipment, CG Bio unveiled several products crucial for spinal fixation and fusion. Notable products included the pedicle screw system Colonnade, the height-expandable spinal cage Xcender, the bone substitute Novosis, and demineralized bone matrix-based bone graft materials Bongener and Allomix. CG Bio currently supplies Novosis to the New Zealand market through Australian distributor LifeHealthcare. The company aims to expand its biologics and spinal implant product lines in Australia and New Zealand by leveraging its existing distribution network.\n\nCG Bio's CEO, Yu Hyun-seung, emphasized the company's focus on providing comprehensive solutions to medical professionals rather than just individual products. He highlighted that the company would strengthen partnerships in the Australian and New Zealand markets and continue to grow its presence in the global spine surgery market.",
  "summary": "CG Bio, a global regenerative medicine company, participated as a gold sponsor in the '2026 World UBE Society Australia Annual Congress' held in Melbourne, Australia.The event served as a venue to share the latest techniques and clinical experience in the field of unilateral biportal endoscopic surg",
  "key_points": [
    "CG Bio sponsored 2026 World UBE Congress in Melbourne",
    "Company showcased surgical instruments, imaging equipment, implants, and bone regeneration biologics",
    "Introduced key endoscopic spine surgery equipment and products for spinal fixation and fusion"
  ],
  "editors_take": "By showcasing a complete suite of surgical instruments and biologics, CG Bio is positioning itself to capture greater market share across the Australian and New Zealand spinal surgery sectors.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}